High testosterone at this stage will accelerate the process. The SARMs are not testosterone, and don’t get metabolised into DHT (nor estradiol). The SARMs selectively bind to the androgen receptor in muscle and bone and amplify the effect of testosterone and DHT there, while not amplifying the effect on other tissue ie skin, prostate. However, through inheritance, if you have hair androgen receptors that are similar to muscle/bone androgen receptors, then SARMs can amplify the androgen message in the hair follicles, and if the inherited androgen sensitivity is activated, it could lead to accelerated male pattern baldness. This is a very rare variation, and while possible, is uncommon. There are no tests available to determine SARMs effect on your hair follicles, nor to determine when your genetic androgen sensitivity in hair follicles will activate.


The increase in GH secretion due to IPAMORELIN (and other GHRP) leads to an increase in IGF-1 (thought to be the anabolic mechanism of GH).  As we get older GH and subsequently IGF-1 decrease substantially.  This decline is thought to be one of the major causes of the ageing process.  By increasing these levels again there is increased collagen synthesis, promotion of lean muscle mass, bone strength, improved healing capability, improved sleep cycle, increased energy, repair and regeneration of internal organs, strengthening of joints/cartilage/connective tissue, and anti ageing effects on the skin. 


The response of these wounds reminds us of the pattern of healing described for MG53 protein (a membrane repair machinery member), so that the treatment facilitated wound healing along with a reduced scarring in rodent models. This antiscar effect was explained by interfering with TGF-β-dependent activation of myofibroblasts differentiation and reduction of ECM proteins accumulation [22]. Similarly, antiscarring healing properties are described for plants’ principles that downregulate the expression of fibrogenic-related molecules such as TGF-β1 and the downstream events, leading to fibrosis and scar formation [23]. In addition to a direct action of GHRP-6 on TGFB1 gene expression, we deem that the reduction of inflammatory effectors could have also contributed to enhancing the healing process and to reducing fibrosis. In an animal model of liver ischemia/reperfusion, we previously demonstrated that GHRP-6 prevented internal organs parenchymal activation and the onset of a systemic inflammatory response syndrome by downregulating proinflammatory cytokines [24]. Subsequent studies have demonstrated the ability of different GHRPs to ameliorate local and systemic inflammatory processes in a variety of experimental scenarios by suppressing the activation of NF-κB, the consequent expression of proinflammatory cytokines, and acting as chemokine receptor antagonist [25–27]. Differentiation to myofibroblasts, collagen fibrillogenesis, and matrix accumulation are controlled by opposing forces: proinflammatory and profibrogenic, that require a fine tuning to ensure a proper esthetic healing and effective mechanical properties of the ECM [28, 29]. The overall interpretation of the data from (i) the rate of closure, (ii) microscopic appearance of the collagen fibrils alignment/organization, (iii) impact of the treatment on the transcriptional expression of cytoskeleton filamentous proteins (smooth muscle α-actin (α-SMA), desmin, and vimentin) supports the hypothesis that, in this context, GHRP-6 has shifted the balance toward “a more regenerative” rather than a reparative phenotype.
The effect of GHSs on GH release is dose dependent and more reproducible than that of GHRH. The peptide GHSs (e.g., GHRP-6, GHRP-1, GHRP-2, and hexarelin) and the nonpeptide GHSs differ in terms of their pharmacokinetics. The nonpeptides MK-0677 and macimorelin have been developed specifically as orally active agents. The peptidyl GHSs are also active PO, but only at doses several hundred times higher than that required when administered IV.
The other submission commented on the consideration to place AOD-9604 in Appendix D. The submission supported listing in Schedule 4, but raised concerns that listing the substance in Appendix D would limit any future development work, including clinical trials that are currently being conducted on the substance. The submitter notes that there are currently 5 clinical trials notified to the TGA using this substance , with these approved clinical trials going ahead on the basis that the substance is safe for human use. Inclusion in Appendix D may place unnecessary burden on those conducting these clinical trials.
Effect of GHRP-6 on the left ventricular ejection fraction in an experimental model of dilated cardiomyopathy (DCM). Echocardiography data were derived from our DCM model including the prevention and the regression study protocols in rats.35 The prevention protocol conceived the concurrent administration of GHRP-6 as part of a prolonged treatment with doxorubicin. The concomitant GHRP-6 completely prevented cardiac function failure evaluated as the percentage of ejection fraction by echocardiography. The regression approach examined the GHRP-6 intervention once LVEF was already deteriorated. As shown, the therapeutic administration schedule introduced a full functional recovery of cardiac muscle. Data corresponding to percentage of ejection fraction (%EF) are represented as a mean value ± standard error of the mean for each experimental group. (*), (**), and (***) represent the statistically significant differences between groups treated either with placebo or GHRP-6, according to Student’s t-test.

Figure 3: Impact of GHRP-6 treatment on wound angiogenesis. Anti-CD31 immunolabeling for mature endothelial cells. Images are representative of (a) vehicle (1% CMC)-treated wounds; (b) GHRP-6-treated wounds. No histological differences were detected between the groups in relation to the number of neovessels, their structure, distribution, organization, or CD31 positivity.
GHRP-6 is a potent stimulator of natural Growth Hormone release. GHRP-6 is a Hexa-peptide that promotes food intake by stimulating hunger and helps increase energy metabolism. Growth Hormone Releasing Peptides, similar to GHRP-6, are most commonly used for treatment of Growth Hormone (GH) deficiencies, eating disorders, obesity, etc. Research has shown that use of these HGH Peptides increases lean muscle mass, strength, stamina and decreases body fat.
I was keen to try out CJC 1295 because my gym buddies had been using it for a while with fast and positive results. Though I was a bit nervous about injecting myself! To my surprise, it was easier than I expected. So I ordered online with Peptides Clinics and received a fast and efficient service. Everything came packaged in ice packs and with relevant info. Initially, I tried with the lowest dosage of CJC-1295 which was 10 mg for 10 weeks. It wasn’t look before I was seeing results. In fact, I noticed pretty quickly an increase in lean muscle, and couldn’t believe the amount of weight I lost! Brilliant! But, I have been advised to try out the CJC 1295 Ipamorelin combination, which I will do soon!
There is evidence of involvement of organised crime in supply of the substances. The substances are offered for sale via the internet. Many of the substances are promoted as safe alternatives to traditional performance enhancing substances such as the anabolic steroids. Suppliers are making unproven assertions about the efficacy and safety of the substances.
The consumption of all dairy products have been shown to naturally raise IGF-1 levels , but I personally go straight to the source and both drink camel milk and other forms of raw milk (in moderation) and use goat’s milk colostrum. In scientific studies, colostrum supplements have proven to increase the amount of IGF-1 and IgA in the bloodstream (IgA is an important immunoglobulin that helps to ensure our immunity to pathogens, especially in the mucous membranes).
Mostly, these peptides are sold as lyophilized powder in 2mg containers. Bacteriostatic water should be mixed with the powder in order to reconstitute it. To make the dosage of 100mcg per injection, 2ml bacteriostatic water should be mixed into 2mg of lyophilized powder. This reconstituted mixture should be then injected inside the muscles or under the skin. The mixture should be kept under refrigeration at all times otherwise it will degenerate and will not be effective anymore.
Peptidyl and nonpeptidyl GHSs are active when administered by intranasal and oral routes, are more potent on a weight basis than GHRH itself, are more effective in vivo than in vitro, synergize with coadministered GHRH and are almost ineffective in the absence of GHRH, and do not suppress somatostatin secretion. Prolonged infusions of GHRP amplify pulsatile GH secretion in normal men. GHRP administration, like that of GHRH, facilitates slow-wave sleep. Patients with hypothalamic disease leading to GHRH deficiency have low or no response to hexarelin; similarly, pediatric patients with complete absence of the pituitary stalk have no GH secretory response to hexarelin.
Furthermore, the most potent profibrogenic growth factors: Tgfb1, Pdgfb, and Ctgf also appeared significantly underexpressed in the GHRP-6-treated wounds (all ) (Figure 4). In line with this, we observed a significant reduction in the expression levels of Col1a1 and Col3a1 (Figure 4, both ). Concomitantly, we addressed the attention to filamentous and contractile proteins associated with fibroblasts and other differentiated mesenchyme-derived cells. Acta2 appeared close to a significant reduction (), whereas Des, Vim, and Fn transcriptional expression appeared significantly reduced (all ), as compared to placebo-treated wounds.
[D-Lys3]-GHRP6 (growth hormone releasing peptide 6) induces the secretion of growth hormone (GH). In the membrane of clonal GC somatotropes, this peptide elevates the number of functional voltage-gated Ca2+ and Na+ channels. Chronic treatment with this peptide causes an elevation in Na+ macroscopic current in bovine pituitary somatotropes in culture, which results in an increase in the release of GH.
Our group recently demonstrated the antifibrotic effects of the growth hormone-releasing peptide 6 (GHRP-6) in a rat model of liver cirrhosis. GHRP-6 prevented parenchymal fibrotic induration in more than 85% and removed in about 75% the accumulated fibrotic material in both preventive and therapeutic administration schemes. Differentially expressed genes in a microarray experiment indicated that GHRP-6 modulates the expression of genes involved in the redox metabolism, as in the mesenchymal cells response to injury [7].

Technically, it is a “protein-peptide hormone” which means that it consists of 70 amino acids bonded together. Just like the peptides I’ve written about in the past, this means that it must be injected, because otherwise IGF-1 simply degrades in the gut, rendering it useless. Your own human growth hormone release promotes the synthesis of IGF-1 in your liver (and to smaller amounts, synthesis of IGF-1 by your muscles), your liver and muscles then synthesize IGF-1 and then, in the case of your liver, subsequently package the IGF-1 with binding proteins for transport into the blood. In a type of anabolic positive-feedback loop, IGF-1 then further increases growth hormone’s anabolic effects.


One submission was received, which did not support the delegate's interim decision, as available data support that the fixed dose paracetamol/caffeine combination product provides clinically meaningful efficacy over paracetamol alone; has an excellent safety profile; a very low risk of nephrotoxicity, toxicity in overdose, misuse, abuse or illicit use; and a highly favourable risk/benefit profile.

One more way for growth hormone to help with fat loss is that this sustains the levels of blood glucose through inhibiting glucose uptake to the peripheral cells, reducing the glucose oxidation for the energy in cells and thus boosting the production of the glucose in the cells from amino acids and fats. The blood’s free fatty acids from lipolysis also partially obstruct the insulin receptors on the cell membranes, reducing insulin’s effectiveness in triggering glucose removal from the blood that causes decreased sensitivity to insulin or insulin resistance. These will then result to fat loss, particularly from the difficult to move intra-abdominal storages of fat.

Very tough to say. I am not a doctor and this is not to be taken, interpreted or construed as medical advice. Please talk with a licensed medical professional about this. These are just my own personal thoughts and not a prescription or a diagnosis or any form of health care whatsoever. I could possibly help but would need to see your health history, blood, biomarkers, etc. I'd be happy to help you via a personal one-on-one consult. Just go to https://bengreenfieldfitness.com/coaching. and then choose a 20 or 60 minute consult, whichever you'd prefer. I can schedule ASAP after you get that.

I stopped the colostrum and my ” symptoms ” subsided, seems I have a moderately enlarged prostate which doesn’t run in my family on either side, my question is could the colostrum possibly cause the prostate to enlarge due to the igf-1 at a certain age,? due to a possible decline in testosterone, or could the benefits of colostrum outweigh the prostate issue?
[D-Lys3]-GHRP6 (growth hormone releasing peptide 6) induces the secretion of growth hormone (GH). In the membrane of clonal GC somatotropes, this peptide elevates the number of functional voltage-gated Ca2+ and Na+ channels. Chronic treatment with this peptide causes an elevation in Na+ macroscopic current in bovine pituitary somatotropes in culture, which results in an increase in the release of GH.
IGF-1 also increases the activity of muscle protein synthesis and the activity of muscle stem cells (also called satellite cells) for repair of damaged muscle. This is probably why intense weight training is one primary stimulus for a natural release of IGF-1 in muscle. As a matter of fact, exercise researchers have found that systemic IGF-1 normally produced in the liver isn’t even required for this type of muscle repair, as other IGF-1 forms produced by your own muscles during and post-exercise allows for adequate muscle tissue repair.
Peptides is from the latin word pepsis which means digestion. So in reality they cover anything in the body that aids digestion and since we get all our nutrients from this process the use of peptides is seemingly limitless. Recently biologically active peptides have been discovered in the heart, brain and skin so the potential uses and benefits of peptides in the future is really exciting.
Despite all these pharmacological advantages and that GHRPs exhibit a broad safety profile, their clinical development has been erratic and irregular. This has been a deterrence factor for their definitive positioning within cardiology and intensive care medicine for years. In the meantime, novel drugs and therapeutic strategies are demanded to protect organs and tissues exposed to ischemia and other lethal insults in the clinical practice.
IGF-1 also increases the activity of muscle protein synthesis and the activity of muscle stem cells (also called satellite cells) for repair of damaged muscle. This is probably why intense weight training is one primary stimulus for a natural release of IGF-1 in muscle. As a matter of fact, exercise researchers have found that systemic IGF-1 normally produced in the liver isn’t even required for this type of muscle repair, as other IGF-1 forms produced by your own muscles during and post-exercise allows for adequate muscle tissue repair.
All relevant GH side effects of numb/tingling hands and arms (especially at night), and water retention will be experienced by the user, but it also has a tremendouse hunger influencing side effect due to its ability to mimic GHRELIN (the hormone that makes our stomach growl and makes us want to eat). Obviously, ravenous hunger isn’t something one would want during a contest diet phase so one might swap from GHRP-6 to GHRP-2, another GH secratagogue which does not make you hungry but which I find is slightly less effective in GH release doses being equal. During the off-season however, hunger can be the bulking bodybuilders’ best friend, so I like to include GHRP-6 solely for this effect in some instances (GH influence aside), in myself and the athletes I help who struggle to find the appetite needed to get through all the food sometimes needed to pack on serious off-season mass.
Consistent with these data, our group observed a transient inotropic effect of about 15 minutes in both healthy and infarcted rabbits following a single GHRP-6 intravenous bolus (400 µg/kg). Echocardiography recordings indicated a 15%–20% elevation of the ejection fraction as an increase in shortening fraction (Juan Valiente Mustelier and Jorge Berlanga Acosta, unpublished observations, 2007). More recent studies based on isolated murine hearts that underwent periods of ischemia and reperfusion (I/R) confirm that pre- or posttreatments with hexarelin for instance prevented the intracellular disturbances in Ca+2 transients through recovery of p-PLB after the I/R insult.43 Other studies involving adult Wistar rat ventricular myocytes have confirmed the positive inotropic response induced by hexarelin and other secretagogue peptides that bind the GHS-R1a, which activates protein kinase C signaling cascade.44
Another side effect of the CJC-1295 is acromegaly, since it helps in increasing the levels of the growth hormone. Acromegaly is a condition where extra growth hormone is released even after the internal organs and the skeleton have finished growing. This causes thickening of the skin, deepening of voice, enlargement of jaws, and slurring of speech. Another effect of acromegaly is the swelling of the soft tissue in the internal organs. This could result in the weakening of the muscles of the internal organs, like the heart. This was tested during the phase 2 testing of CJC-1295.
© 2010-2017 Copyright HGH.com and Purity Select, Inc. None of our statements have been evaluated by the Food and Drug Administration. Our products are not intended to diagnose, treat, cure or prevent any disease. All products sold on this web site are intended for adults over the age of 18 and are not to be used by children under the age of 18. We do not have any clinical studies backing up our claims. Individual results will vary. Do not use more than the daily dose recommended on the label of each product. Please speak with your primary care physician before purchasing or starting the use of any supplement.
MuscleSport PCT Stack 1x MuscleSport PCT Revolution 1x MuscleSport Test Revolution Black The MuscleSport PCT Stack is the ultimate Post Cycle Therapy supplement combo. Perfect for anyone who has spent time using anabolics or SARMs and want to ensure that their natural testosterone production is at its peak and that any excess estrogen is taken care of.  
For example, insufficient protein or calories can cause IGF-1 to plummet, while ample calories can cause IGF-1 to increase. For example, one study of women who fed with excess calories over and above their normal metabolic rate noted a 19% increase in IGF-1 after two weeks of overfeeding, with 46% of the weight gain from  lean mass and 54% from bodyfat. Fasting insulin doubled in these women, and testosterone levels also significantly increased.
also using a dose of 400mcg for the IPAM is really a waste of your peptides as anything above saturation dose will give diminished returns, saturation dose(1mcg per kg) is a dose that will give maximum return, if you double the saturation dose then you will not get double the GH pulse in fact no where near that, then the more you use the less added benefit you will get.
As both CJC1295 and Ipamorelin bind to the pituitary gland and prompt the release of GH, when used together, the production of growth hormone is over 10 times more than when used individually. As it stimulates the body’s natural growth hormone production it also causes the release of IGF-1. The advantages of the CJC peptide is that it helps increases bone density and collagen, as well as boosting the immune system. It will also produce new muscle cells which will be leaner and increases weight loss. The CJC 1295 results are part of years of scientific studies. It primarily increases the production of proteins, which leads to stable bodily functions related to the glands in the body or the endocrine system.
The original GRF (1-29) has a half-life of about 30 minutes. Half-life means the time within which half of the hormone administered will be destroyed within the body. This short half-life is due to the fact that the compound is highly unstable and breaks down soon. To increase its stability and to make it last longer, it was modified by adding 4 amino acids in its structure. This gave it the name Modified GRF (1-29) or Mod GRF 1-29. It was originally invented by DatBtrue. The portion of the molecule that actually stimulates the growth hormone secretion is found in the chain of 29 amino acids, so it is named GRF (1-29). This chemical also produces slow-wave sleep.
Application would result in all current OTC paracetamol/ phenylephrine products being up-scheduled to S3. Applicant’s justification for changing current combination products from exempt or S2 to S3 is on theoretical basis only, and no evidence provided of clinical risk. Pharmacokinetic study found that co-administration of paracetamol with phenylephrine increased plasma phenylephrine levels - applicant says this has potential for cardiac safety risk in susceptible patients.
Growth Hormone Releasing Peptide 6 ( GHRP-6) is a peptide which substantially activates the pituitary gland into releasing high levels of growth hormone for a few hours. The increase in growth hormone comes from your own body, not synthetic growth hormones which can suppress your natural production. GHRP 6 is a first generation GHRP and has a few side effects which could be annoying.

GHRP-6 is normally always manufactured as lyophilized (freeze-dried) powder contained in vials in amounts of 5mg. Some companies might manufacture amounts greater or lesser than 5mg per vial, but the standard is generally 5mg/vial. The lyophilized powder contained within the vial will need to be reconstituted with bacteriostatic water in order for it to be injected. After reconstitution, the solution must then be refrigerated in storage. If left in hot environments or in room temperature environments for extended periods of time, the protein structure will degrade and become ineffective. For reconstitution, users will typically mix 3ml of bacteriostatic water with the powder gently. However, users can and do frequently reconstitute the powder with less (or more) water which will yield different concentrations of GHRP-6. For example, reconstitution of 5mg of powder with 3ml of water will yield GHRP-6 doses of 166mcg per 0.1ml (or 10iu on an insulin syringe).


Our hormone levels decline as we age, and therefore the effects of these hormones decline proportionally. Even if you exercise and eat well, you will still experience this decline in hormone production and all of the associated adverse health effects that this brings. To fight ageing, and increase vitality, we can restore our hormones to their youthful levels.
Increase in ghrelin – Ghrelin is a hormone that the stomach releases when it is empty. It also helps regulate appetite, promotes fat loss in muscle tissue, and helps in healing damaged tendons. There are studies which also point to a direct link between elevated levels of ghrelin and faster repair of tendons. GHRP-6 causes an increase of ghrelin in the body.

Biokey Research OSTA-MAX 25 BRAND: BIOKEY RESEARCH  OSTARINE (MK-2866) Purity : 99% Molecular Formula : C19H14F3N3O3 Molecular Weight: 389.33 CAS#: 841205-47-8 Description: MK-2866 Ostarine 30ml @ 25mg per ml Recommended dosage: 0.5-1ml daily DESCRIPTION OSTA-MAX 25 by BioKey Research contains 25mg/ml of MK-2866. This compound is often compared it its illegal anabolic counterparts due its ability to reduce body fat while increasing lean muscle mass. OSTA-MAX 25…


Remember the GHRP you select is used for a few reasons. One is to prompt the release of the increase pulse in GH you have initiated with the GHRH you have selected to use. This is by inhibition of Somatostatin. So you are actually selecting the timing of the release of your natural production of  still physiologic amount of GH.  Another reason is to actually contribute a little more to the amplitude of you GH pulse.
GHRP-6 side effects that are the result of the HGH increases include: flu-like symptoms, joint pain, and carpal tunnel syndrome, headaches, and bloating and water retention. Less likely side effects include: dizziness, tingling or numbness on the skin, reduction of touch sensitivity, nausea, sore bones, and gynecomastia. Although HGH is not a sex hormone, it does serve as an important mediator hormone that works with Estrogen in the development of gynecomastia[1]. This should be kept in mind when utilizing GHRP-6 (or any HGH related compound) with aromatizable anabolic steroids.

GHRPs are not simply surrogates of GHRH, instead GHRP-6 is an artificial activator of a separate newly discovered receptor called Growth Hormone Secretagogue Receptor (GHS-R). Soon Ghrelin was discovered, the endogenous ligand that binds to the GHS-R. Both Ghrelin and all the synthetic compounds such as GHRP-6 were termed "Growth Hormone Secretagogues" (GHSs). One side effect of GHRP-6 is a significant increase in appetite due to stimulating the release of Ghrelin, a peptide that is released naturally in the lining of the stomach that increases hunger and gastric emptying. Also, GHRP-6 causes stimulation of the anterior pituitary gland which causes an increase in Growth Hormone release. The increased amounts of Growth Hormone can cause the liver to secrete the hormone IGF-1, which improves the animal body’s ability to burn fat and build muscle. Since GHRP-6 acts directly on the feedback loop which signals the inhibition of Growth Hormone release, GHRP-6 can re-stimulate the production of Growth Hormone.


To our knowledge, this company collects reviews by asking its customers to share their experiences on Trustpilot. Read more This company has claimed its Trustpilot profile, but to our knowledge, doesn't actively invite its customers to write reviews on Trustpilot. Read more This company hasn't claimed its Trustpilot profile and to our knowledge, doesn't actively invite its customers to write reviews on Trustpilot. Read more
We are filling in a long needed position in the industry, and building our reputable brand with reliability and trust. We found no all round affordable website that sells research chemicals where the price was affordable, chemicals proven pure and customer service is top notch. All business's in this industry currently lack in at least one of these three important areas. We are here to be the reliable bridge between excellent chemicals and you.

The experiment in rats, based on clean full-thickness controlled wounds, indicated that GHRP-6 pharmacodynamics has likely involved attenuation of immunoinflammatory mediators, their effector cells, and the reduction of fibrosis-inducing cytokines. The concerted action of these two elemental mechanisms may have theoretically translated into a particular modulation of fibroblasts response to injury, leading to precocious closure with a reduced scarring. Outstandingly, the mechanisms underlying this pattern of healing do not appear to interfere with the angiogenic repopulation nor with the reepithelialization process.
As we mentioned above, the results you are going to realize are different for each user. An athlete might see immediate and greater gains, than a 50-year old male who has never stepped foot in a gym and is 30 pounds overweight. So, make sure you bear this in mind as you are determining whether or not Ipamorelin is right for you. Further, if incorporating other supplements like CJC 1295 or additional growth hormones, the results are also going to be greater than if you are simply using Ipamorelin on its own. Make sure you are aware of this, and how to properly incorporate it with other supplements, in order to ensure the best possible results with use.
During studies of the opioidal control of GH secretion several analogs of met-enkephalin were found to be potent GH secretagogs. Among them were GH-releasing peptide-6 (GHRP-6), and hexarelin (His-D2MeTRP-Ala-Trp-DPhe-Lys-NH2) (Laron, 1995). They act via a receptor unrelated to that of GHRH (Howard et al., 1996). The potent biologic action of the GHRPs and the identification of a specific receptor suggested the existence of a natural ligand.

The effect of GHSs on GH release is dose dependent and more reproducible than that of GHRH. The peptide GHSs (e.g., GHRP-6, GHRP-1, GHRP-2, and hexarelin) and the nonpeptide GHSs differ in terms of their pharmacokinetics. The nonpeptides MK-0677 and macimorelin have been developed specifically as orally active agents. The peptidyl GHSs are also active PO, but only at doses several hundred times higher than that required when administered IV.
Despite the controversies, some scientists continued with additional studies and again proved IGF-1 to actually prolong life…at least in worms.  Then, in 2001, scientists discovered that the use of IGF-1 resulted in a proliferation of cancer cells, especially throughout the breast and colon, and a 2012 study found that both too much or too little IGF-1 could contribute to dying from cancer; implying that IGF-1 actually helped patients with terminal cancer live longer.

The growth hormone-releasing peptide-6 (GHRP-6) is one of several synthetic met-enkephalin analogs that include unnatural D-amino acids. They were developed for their growth hormone (GH) releasing activity, then called GH secretatogues. They lack opioid activity but are potent stimulators of GH release. These secretatogues are distinct from the growth hormone releasing hormone (GHRH or GHRF) in that they share no sequence relation and derive their function through action at a completely different receptor, the ghrelin receptor.


GHRH (1 μg/kg) plus GHRP-6 (1 μg/kg) is given intravenously at 0 minutes and blood drawn for GH sampling at 0 and 120 minutes [200]. GH releasing peptide-6 (GHRP-6) is an artificial hexapeptide [96] that activates the ghrelin receptor [98]. Combined administration of GHRP-6 and GHRH is the most potent stimulus to GH release, with excellent reproducibility and no serious side effects [96]. GHRH/GHRP-6 is a viable alternative to the ITT in patients with organic pituitary disease, however there is overlap between GH levels attained in the control group and severely GH-deficient patients. Since GHRH and GHRP act directly on the pituitary, it is possible that their administration restores GH secretion in patients with a deficiency of these secretagogues because of hypothalamic disease [201].
GHRP-6 is a small molecular weight peptide, effective when orally administered, stable, and economically low priced than others.13 Our observation that GHRP-6 intravenous administration proved to be safe in a dose scale-up clinical trial in healthy human volunteers is significantly important.14 Our demonstration that there is no in vivo pharmacological interaction between the peptide and a well-validated cardiovascular drug such as the beta blocker agent metoprolol is also relevant for GHRP-6 pharmacological “positioning”.15 Since for years, GHRP-6 has been the platform of our experimental work; we address particular attention to its investigational development as for hexarelin and GHRP-2.
×